Bradford T Whitmore Nanophase Technologies Corp (NANX) insider trading activity

Bradford T Whitmore is > 10% Shareholder of NANOPHASE TECHNOLOGIES Corp. Currently has a direct ownership of 25.5 Million shares of NANX, which is worth approximately $47.9 Million. The most recent transaction as insider was on Feb 08, 2024, when has been sold 2,791,725 shares (Common Stock) at a price of $0.4 per share, resulting in proceeds of $1,116,690. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.5M

0% 3M change

16.25% 12M change

Total Value Held $47.9 Million

BRADFORD T WHITMORE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 08 2024	BUY Open market or private purchase	$1,116,690 $0.4 p/Share	2,791,725 Added 9.88%	25,467,020 Common Stock
Aug 23 2023	BUY Open market or private purchase	$2,352 $1.12 p/Share	2,100 Added 0.01%	30,406,868 Common Stock
Aug 22 2023	BUY Open market or private purchase	$35,989 $0.91 p/Share	39,549 Added 0.13%	30,404,768 Common Stock
Aug 21 2023	BUY Open market or private purchase	$40,662 $0.92 p/Share	44,198 Added 0.15%	30,365,219 Common Stock
Jun 01 2023	BUY Open market or private purchase	$605 $1.21 p/Share	500 Added 0.0%	30,321,021 Common Stock
May 31 2023	BUY Open market or private purchase	$9,086 $1.18 p/Share	7,700 Added 0.03%	30,320,521 Common Stock
May 30 2023	BUY Open market or private purchase	$9,676 $1.18 p/Share	8,200 Added 0.03%	30,312,821 Common Stock
May 19 2023	BUY Open market or private purchase	$6,723 $1.19 p/Share	5,650 Added 0.02%	30,304,621 Common Stock
May 18 2023	BUY Open market or private purchase	$8,528 $1.04 p/Share	8,200 Added 0.03%	30,298,971 Common Stock
May 17 2023	BUY Open market or private purchase	$40,840 $0.77 p/Share	53,040 Added 0.17%	30,290,771 Common Stock
Dec 15 2022	BUY Open market or private purchase	$330,536 $1.1 p/Share	300,488 Added 0.98%	30,237,731 Common Stock
Dec 08 2022	BUY Open market or private purchase	$106,719 $1.16 p/Share	92,000 Added 0.31%	29,937,243 Common Stock
Dec 07 2022	BUY Open market or private purchase	$526 $1.17 p/Share	450 Added 0.0%	29,845,243 Common Stock
Dec 06 2022	BUY Open market or private purchase	$105,307 $1.22 p/Share	86,318 Added 0.29%	29,844,793 Common Stock
Nov 18 2022	BUY Open market or private purchase	$102,760 $1.4 p/Share	73,400 Added 0.25%	29,758,475 Common Stock
Nov 17 2022	BUY Open market or private purchase	$65,080 $1.38 p/Share	47,160 Added 0.16%	29,685,075 Common Stock
Nov 16 2022	BUY Open market or private purchase	$17,675 $1.4 p/Share	12,625 Added 0.04%	29,637,915 Common Stock
Dec 21 2021	SELL Open market or private sale	$32,395,291 $4.19 p/Share	7,731,573 Reduced 26.1%	21,893,717 Common Stock
May 07 2021	BUY Conversion of derivative security	$2,019,111 $0.2 p/Share	10,095,555 Added 25.42%	29,625,290 Common Stock
Sep 29 2020	BUY Other acquisition or disposition	-	2,433,300 Added 11.08%	19,529,735 Common Stock

Also insider at

CLSD

Clearside Biomedical, Inc. Healthcare

> 10% Shareholder

ULBI

ULTRALIFE CORP Industrials

Director

BTW